Shilpex Pharmysis is an emerging pharmaceutical company offering PCD Pharma Franchise opportunities for Eye Drops across India. Based in New Delhi, the company focuses on providing quality healthcare products across multiple therapeutic segments, with a dedicated ophthalmic range for eye-care requirements.

The company's ophthalmic portfolio includes products such as INSTATEAR-Eye Drops, containing Sodium Hyaluronate, and OLOVIS Eye Drops, containing Olopatadine. Its broader product range also includes ophthalmic gels and other pharmaceutical formulations in tablets, capsules, syrups, injections, and topical dosage forms.

Shilpex Pharmysis operates through a marketing and distributor network and offers pharmaceutical business opportunities for partners interested in specialized healthcare segments. Its PCD franchise approach is supported by product availability, distribution assistance, promotional support, and a diversified portfolio covering ophthalmology, cardiology, diabetology, dermatology, gynecology, neurology, orthopedics, respiratory care, nutrition, and gastroenterology.

With its focus on quality medicines, affordable healthcare, and expanding distribution reach, Shilpex Pharmysis continues to develop its presence in India's pharmaceutical market. Its dedicated ophthalmic portfolio makes it a relevant choice for entrepreneurs searching for a PCD Pharma Franchise Company for Eye Drops and other eye-care products.